FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124840772> ?p ?o ?g. }

• W2124840772 endingPage "1872" @default.
• W2124840772 startingPage "1863" @default.
• W2124840772 abstract "The Chronic Obstructive Pulmonary Disease Early Intervention Trial, or Lung Health Study, is a multicenter randomized clinical trial sponsored by the Division of Lung Diseases of the National Heart, Lung, and Blood Institute. The hypothesis being tested is that over a 5-year period, a comprehensive intervention program can reduce both the rate of decline in pulmonary function and the rates of respiratory morbidity and mortality in middle-aged smokers with mild to moderate airflow obstruction. The primary outcome variable of the trial is the annual rate of decline of maximum postbronchodilator FEV1. Secondary outcomes are the development of respiratory and nonrespiratory morbidity and mortality. After screening 73,694 cigarette smokers, aged 35 to 60 years, 5,887 participants were randomized into three equal groups: usual care, smoking intervention with daily use of a metered-dose inhaler with ipratropium bromide, and smoking intervention with inhalation of placebo. Eligible participants had a ratio of FEV1 to forced vital capacity (FVC) of 70 percent or less, were free of known life-limiting conditions, expressed willingness to enter the intervention program if so randomized, and gave written informed consent prior to entry into the trial. Spirometry, methacholine challenge, and questionnaires were strictly standardized within and across centers. The purpose of this report is to describe the characteristics of randomized participants at the time of entry into the study. For both sexes, three measures of lung function--average cross-sectional FEV1/FVC ratio, FEV1, and FEV1 percentage of predicted normal--showed slight downward trends for each successively older 5-year age cohort. The increase in FEV1 after isoproterenol was 15 percent or more in only 2.4 percent of men and 2.8 percent of women. A positive response to methacholine (defined as a fall in FEV1 of > 20 percent from baseline at concentrations up to 25 mg/ml) occurred in 63 percent of men and 87 percent of women. The cross-sectional prevalences of cough, phlegm, wheeze on most days or nights, and shortness of breath were 49 percent, 43 percent, 32 percent, and 43 percent, respectively. Respiratory symptoms were reported by a higher proportion of participants in the younger age groups than in the older age groups. Participants who reported cough, phlegm, and/or wheeze averaged lower FEV1 percent predicted and higher probability of positive response to methacholine than participants who did not. Shortness of breath appeared to be significantly associated with lower lung function and higher reactivity in men but not in women.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2124840772 created "2016-06-24" @default.
• W2124840772 creator A5030333301 @default.
• W2124840772 creator A5034195605 @default.
• W2124840772 creator A5051214320 @default.
• W2124840772 creator A5054727332 @default.
• W2124840772 creator A5067305173 @default.
• W2124840772 creator A5089798726 @default.
• W2124840772 date "1993-06-01" @default.
• W2124840772 modified "2023-09-27" @default.
• W2124840772 title "Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study)" @default.
• W2124840772 cites W1969800898 @default.
• W2124840772 cites W1976108398 @default.
• W2124840772 cites W1982123427 @default.
• W2124840772 cites W1985596801 @default.
• W2124840772 cites W2018987279 @default.
• W2124840772 cites W2043657101 @default.
• W2124840772 cites W2053445414 @default.
• W2124840772 cites W2059718063 @default.
• W2124840772 cites W2066780555 @default.
• W2124840772 cites W2137080296 @default.
• W2124840772 cites W2156124195 @default.
• W2124840772 cites W4244598283 @default.
• W2124840772 cites W4249200669 @default.
• W2124840772 doi "https://doi.org/10.1378/chest.103.6.1863" @default.
• W2124840772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8404115" @default.
• W2124840772 hasPublicationYear "1993" @default.
• W2124840772 type Work @default.
• W2124840772 sameAs 2124840772 @default.
• W2124840772 citedByCount "79" @default.
• W2124840772 countsByYear W21248407722012 @default.
• W2124840772 countsByYear W21248407722013 @default.
• W2124840772 countsByYear W21248407722014 @default.
• W2124840772 countsByYear W21248407722015 @default.
• W2124840772 countsByYear W21248407722017 @default.
• W2124840772 countsByYear W21248407722018 @default.
• W2124840772 countsByYear W21248407722021 @default.
• W2124840772 countsByYear W21248407722023 @default.
• W2124840772 crossrefType "journal-article" @default.
• W2124840772 hasAuthorship W2124840772A5030333301 @default.
• W2124840772 hasAuthorship W2124840772A5034195605 @default.
• W2124840772 hasAuthorship W2124840772A5051214320 @default.
• W2124840772 hasAuthorship W2124840772A5054727332 @default.
• W2124840772 hasAuthorship W2124840772A5067305173 @default.
• W2124840772 hasAuthorship W2124840772A5089798726 @default.
• W2124840772 hasBestOaLocation W21248407721 @default.
• W2124840772 hasConcept C126322002 @default.
• W2124840772 hasConcept C142724271 @default.
• W2124840772 hasConcept C165637977 @default.
• W2124840772 hasConcept C168563851 @default.
• W2124840772 hasConcept C1862650 @default.
• W2124840772 hasConcept C204787440 @default.
• W2124840772 hasConcept C27081682 @default.
• W2124840772 hasConcept C2776042228 @default.
• W2124840772 hasConcept C2776780178 @default.
• W2124840772 hasConcept C2777714996 @default.
• W2124840772 hasConcept C2780333948 @default.
• W2124840772 hasConcept C2780532441 @default.
• W2124840772 hasConcept C2781018748 @default.
• W2124840772 hasConcept C3018587741 @default.
• W2124840772 hasConcept C55520419 @default.
• W2124840772 hasConcept C71924100 @default.
• W2124840772 hasConcept C75603125 @default.
• W2124840772 hasConceptScore W2124840772C126322002 @default.
• W2124840772 hasConceptScore W2124840772C142724271 @default.
• W2124840772 hasConceptScore W2124840772C165637977 @default.
• W2124840772 hasConceptScore W2124840772C168563851 @default.
• W2124840772 hasConceptScore W2124840772C1862650 @default.
• W2124840772 hasConceptScore W2124840772C204787440 @default.
• W2124840772 hasConceptScore W2124840772C27081682 @default.
• W2124840772 hasConceptScore W2124840772C2776042228 @default.
• W2124840772 hasConceptScore W2124840772C2776780178 @default.
• W2124840772 hasConceptScore W2124840772C2777714996 @default.
• W2124840772 hasConceptScore W2124840772C2780333948 @default.
• W2124840772 hasConceptScore W2124840772C2780532441 @default.
• W2124840772 hasConceptScore W2124840772C2781018748 @default.
• W2124840772 hasConceptScore W2124840772C3018587741 @default.
• W2124840772 hasConceptScore W2124840772C55520419 @default.
• W2124840772 hasConceptScore W2124840772C71924100 @default.
• W2124840772 hasConceptScore W2124840772C75603125 @default.
• W2124840772 hasIssue "6" @default.
• W2124840772 hasLocation W21248407721 @default.
• W2124840772 hasLocation W21248407722 @default.
• W2124840772 hasOpenAccess W2124840772 @default.
• W2124840772 hasPrimaryLocation W21248407721 @default.
• W2124840772 hasRelatedWork W1789955178 @default.
• W2124840772 hasRelatedWork W1961645094 @default.
• W2124840772 hasRelatedWork W1983444168 @default.
• W2124840772 hasRelatedWork W2149893136 @default.
• W2124840772 hasRelatedWork W2366256932 @default.
• W2124840772 hasRelatedWork W2375063122 @default.
• W2124840772 hasRelatedWork W2807802647 @default.
• W2124840772 hasRelatedWork W3111354819 @default.
• W2124840772 hasRelatedWork W4381739206 @default.
• W2124840772 hasRelatedWork W2189486821 @default.
• W2124840772 hasVolume "103" @default.
• W2124840772 isParatext "false" @default.
• W2124840772 isRetracted "false" @default.

• next